Understand the source comparison
Quickcomparison
Dose Range PNC-27 1–2 mg LL-37 0.5–1.6 mg/mL (topical) Frequency Once daily Administration Subcutaneous injection Topical application (wound healing) Cycle Length 4-6 weeks 12+ weeks Onset Speed Rapid (hours to days) Moderate (1-2 weeks) Evidence Level Strong
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dose Range
- PNC-27
- 1–2 mg
- LL-37
- 0.5–1.6 mg/mL (topical)
- Frequency
- Once daily
- Administration
- Subcutaneous injection
- Topical application (wound healing)
- Cycle Length
- 4-6 weeks
- 12+ weeks
- Onset Speed
- Rapid (hours to days)
- Moderate (1-2 weeks)
- Evidence Level
- Strong preclinical (extensive animal studies)
- Moderate human trials (Phase 1-2)
- Efficacy